CONVERTIBLE PROMISSORY NOTES AND SHORT TERM LOANS (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 17, 2024 |
Feb. 02, 2024 |
Dec. 08, 2023 |
Oct. 25, 2023 |
Oct. 23, 2023 |
Aug. 11, 2023 |
Jul. 18, 2023 |
Jul. 13, 2023 |
Mar. 29, 2023 |
Jan. 23, 2023 |
Dec. 30, 2022 |
Dec. 21, 2021 |
Nov. 30, 2024 |
Feb. 29, 2024 |
Jan. 31, 2024 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Nov. 30, 2022 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Mar. 31, 2021 |
Sep. 25, 2023 |
|
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Issuance of debt | $ 11,756,563 | $ 14,545,805 | ||||||||||||||||||||||||
| Debt conversion description | The redemption price was determined in accordance to the Series B note agreement, where the Company has an option to redeem the note at 115% of its principal value instead of converting the note upon receipt of a conversion notice. The difference between the redemption cash payment and the book value of the note redeemed, including the derivative liability associated to the note | |||||||||||||||||||||||||
| Deferred finance costs | $ 193,437 | |||||||||||||||||||||||||
| Debt face amount | $ 12,400,000 | $ 1,500,000 | ||||||||||||||||||||||||
| Exercise Price | $ 0.50 | |||||||||||||||||||||||||
| Warrants issued | 57,536 | |||||||||||||||||||||||||
| Debt converted amount | $ 2,962,386 | |||||||||||||||||||||||||
| Gains losses on extinguishment of debt | $ (137,934) | 18,539 | ||||||||||||||||||||||||
| Unsecured convertible promissory notes | 1,985,000 | |||||||||||||||||||||||||
| Interest expense | $ 364,000 | |||||||||||||||||||||||||
| Gross proceeds | $ 635,000 | 853,030 | ||||||||||||||||||||||||
| Debt instrument term | 5 years | |||||||||||||||||||||||||
| Maturity date | Dec. 21, 2026 | |||||||||||||||||||||||||
| Finance charge | 50,000 | |||||||||||||||||||||||||
| Accrued interest | 404,621 | 795,656 | ||||||||||||||||||||||||
| Line of credit facility, revolving credit conversion to term loan, description | In assigning the selling accounts receivables to the revolving loan lender, the Company is receiving 85% of their value as an advance of its regular collection of those receivables, limited to $1.2 million in financing, and expects to receive the remaining balance as part of normal collection activities. | |||||||||||||||||||||||||
| Financing receivables | $ 1,200,000 | |||||||||||||||||||||||||
| Inventory financing by facility | $ 300,000 | |||||||||||||||||||||||||
| Accounts receivable, net | 1,541,797 | 1,286,792 | ||||||||||||||||||||||||
| Inventory | 158,000 | 125,000 | ||||||||||||||||||||||||
| Principal outstanding | 1,699,797 | 1,411,792 | ||||||||||||||||||||||||
| Interest expense | 431,356 | 263,696 | ||||||||||||||||||||||||
| Promissory Note Agreement [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument carrying amount | 660,932 | |||||||||||||||||||||||||
| Revolving Credit Facility [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Interest payable | 28,052 | 23,879 | ||||||||||||||||||||||||
| Other Convertible Notes Payable [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 10.00% | |||||||||||||||||||||||||
| Convertible notes payable | $ 2,000,000 | |||||||||||||||||||||||||
| Convertible notes payable | 45,045 | |||||||||||||||||||||||||
| Convertible notes payable | $ 221,621 | |||||||||||||||||||||||||
| Notes Payable, Other Payables [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Unamortized issuance cost discount | $ 186,404 | |||||||||||||||||||||||||
| Adjustment for amortization | 186,404 | |||||||||||||||||||||||||
| Eighteen Month Anniversary [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 12.00% | 12.00% | 12.00% | |||||||||||||||||||||||
| Debt face amount | $ 1,000,000 | |||||||||||||||||||||||||
| Debt converted amount | $ 300,000 | $ 250,000 | ||||||||||||||||||||||||
| Unsecured convertible promissory notes | $ 1,175,000 | |||||||||||||||||||||||||
| Twenty Four Month Anniversary [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 8.00% | |||||||||||||||||||||||||
| Debt converted amount | $ 114,303 | |||||||||||||||||||||||||
| Six Month Anniversary [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 20.00% | |||||||||||||||||||||||||
| Unsecured convertible promissory notes | $ 100,000 | |||||||||||||||||||||||||
| Twelve Month Anniversary [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 10.00% | |||||||||||||||||||||||||
| Unsecured convertible promissory notes | $ 710,000 | |||||||||||||||||||||||||
| Series A Convertible Note Holders [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Warrants issued | 51,101 | |||||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Warrants issued | 51,101 | |||||||||||||||||||||||||
| Warrant [Member] | Placement Agent [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Placement agent fees description | The Company was also obligated to issue warrants to the placement agent that have a 10-year term and cover 12% of funds raised for $8,925,550 (face value) of the notes (first series) and 2.5% of funds raised for the remaining $2,350,000 (face value) of notes (second series), with an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing. On final closing, which occurred on January 8, 2021, the warrants’ exercise price was struck at $6.36 per share. | |||||||||||||||||||||||||
| Preferred Stock [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Interest payable | 36,163 | 4,103 | ||||||||||||||||||||||||
| Two Series A Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Issuance of debt | $ 11,275,500 | |||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 12.00% | |||||||||||||||||||||||||
| Two Series A Notes [Member] | Warrant [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Placement agent fees description | The Company was obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage. The warrants have a 3-year term from date of issuance and an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing. | |||||||||||||||||||||||||
| Series A Notes One [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Description of conversion terms for debt instrument | (i) the Outstanding Balance divided by (ii) 75% of the volume weighted average price of the Common Stock for the 5 trading days prior to the Conversion Date (the conversion price). | |||||||||||||||||||||||||
| Debt conversion description | the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion, redeem the notes for 115% of their face value plus accrued interest. | |||||||||||||||||||||||||
| Series A Notes One [Member] | Placement Agent [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Placement agent fees description | The Company was obligated to pay the placement agent of the first series of Series A Notes a 12% cash fee for $8,925,500 (face value) of the notes and 2.5% cash fee and other sundry expenses for the remaining $2,350,000 (face value) of the notes. | |||||||||||||||||||||||||
| Series A Notes Two [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt conversion description | the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to the lower of $24.00 per share or 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to the lower of $24.00 per share or 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion, redeem the notes for 115% of their face value plus accrued interest. | |||||||||||||||||||||||||
| Conversion price | $ 24.00 | |||||||||||||||||||||||||
| Volume weighted average price of common stock, percent | 75.00% | |||||||||||||||||||||||||
| Series A Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 2,301,854 | |||||||||||||||||||||||||
| Unamortized issuance cost discount | 8,088,003 | |||||||||||||||||||||||||
| Debt face amount | 821,000 | |||||||||||||||||||||||||
| Adjustment for amortization | 49,393 | |||||||||||||||||||||||||
| Series A Notes [Member] | Additional Collateralized Bridge Loan Agreement [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 28,000 | |||||||||||||||||||||||||
| Series A Note [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument carrying amount | $ 500,000 | |||||||||||||||||||||||||
| Interest payable | 272,342 | 173,762 | ||||||||||||||||||||||||
| Interest expense | 98,580 | 98,850 | ||||||||||||||||||||||||
| New Convertible Note [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 12.00% | |||||||||||||||||||||||||
| Debt instrument carrying amount | $ 621,500 | |||||||||||||||||||||||||
| Interest payable | $ 121,500 | |||||||||||||||||||||||||
| Debt instrument interest rate during period | 75.00% | |||||||||||||||||||||||||
| Series B Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt conversion description | The Series B Notes will automatically convert into common stock upon a merger, consolidation, exchange of shares, recapitalization, reorganization, as a result of which the Company’s common stock shall be changed into another class or classes of stock of the Company or another entity, or in the case of the sale of all or substantially all of the assets of the Company other than a complete liquidation of the Company. Within the first 180 days after the issuance date, the Company may, at its discretion, redeem the notes for 115% of their face value plus accrued interest. The Company is obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage. | |||||||||||||||||||||||||
| Deferred finance costs | 10,000 | |||||||||||||||||||||||||
| Unamortized issuance cost discount | 1,312,500 | |||||||||||||||||||||||||
| Debt face amount | 840,000 | |||||||||||||||||||||||||
| Proceeds from convertible debt | $ 1,240,000 | |||||||||||||||||||||||||
| Debt converted amount | $ 555,600 | $ 472,500 | ||||||||||||||||||||||||
| Converted instrument shares issued | 126,833 | 34,586 | ||||||||||||||||||||||||
| Debt instrument periodic payment | $ 126,680 | |||||||||||||||||||||||||
| Cash payment | 145,682 | |||||||||||||||||||||||||
| Convertible notes payable | $ 24,408 | |||||||||||||||||||||||||
| Derivative liabilities | 8,320 | 45,681 | ||||||||||||||||||||||||
| Series B Notes [Member] | Accredited Investors [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt face amount | $ 1,312,500 | |||||||||||||||||||||||||
| Series B Notes [Member] | Warrant [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Warrants and rights outstanding term | 3 years | |||||||||||||||||||||||||
| Series B Notes [Member] | Warrant One [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Exercise Price | $ 6.36 | |||||||||||||||||||||||||
| Warrants issued | 100,000 | |||||||||||||||||||||||||
| Series B Notes [Member] | Warrant Two [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Exercise Price | $ 9.0 | |||||||||||||||||||||||||
| Warrants issued | 35,417 | |||||||||||||||||||||||||
| Series B Note [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Interest payable | 88,881 | 88,602 | ||||||||||||||||||||||||
| Interest expense | 279 | 3,739 | ||||||||||||||||||||||||
| Redemption of convertible notes | 22,009 | 135,710 | ||||||||||||||||||||||||
| Payment redeemed cash | 25,342 | 162,851 | ||||||||||||||||||||||||
| Gains losses on extinguishment of debt | $ 8,320 | 18,540 | ||||||||||||||||||||||||
| Series C Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Issuance of debt | 1,812,700 | |||||||||||||||||||||||||
| Debt instrument interest rate stated percentage | 15.00% | |||||||||||||||||||||||||
| Description of conversion terms for debt instrument | (i) seventy-five percent (75%) of the VWAP for the five (5) Trading Days prior to the Conversion Date, or (ii) eighty percent (80%) of the gross sale price per share of Common Stock (or conversion or exercise price per share of Common Stock of any Common Stock Equivalents) sold in a Qualified Financing (as defined in the Series C note agreements). | |||||||||||||||||||||||||
| Debt conversion description | the notes would convert into common stock at the applicable “Mandatory Conversion Price”, if either (i) on each of any twenty (20) consecutive Trading Days (the “Measurement Period”) (A) the closing price of the Common Stock on the applicable Trading Market is at least $18.00 per share and (B) the dollar value of average daily trades of the Common Stock on the applicable Trading Market is at least $400,000 per Trading Day; or (ii) upon the closing of a Qualified Financing, provided that the dollar value of average daily trades of the Common Stock on the applicable National Exchange on each of the ten (10) consecutive Trading Days following such closing is at least $400,000 per Trading Day. Mandatory Conversion Price means, in the case of a Mandatory Conversion under situation (i) above, seventy percent (70%) of the VWAP over the Measurement Period, or in the case of a Mandatory Conversion under situation (ii) above, eighty percent (80%) of the gross sale price per share of Common Stock (or conversion or exercise price per share of Common Stock of any Common Stock Equivalents) sold in a Qualified Financing. | |||||||||||||||||||||||||
| Unamortized issuance cost discount | 1,232,274 | |||||||||||||||||||||||||
| Interest payable | 53,188 | 253,643 | ||||||||||||||||||||||||
| Adjustment for amortization | 1,267,668 | 693,518 | ||||||||||||||||||||||||
| Interest expense | 70,712 | 251,045 | ||||||||||||||||||||||||
| Proceeds from convertible debt | 1,100,430 | |||||||||||||||||||||||||
| Debt converted amount | $ 150,000 | |||||||||||||||||||||||||
| Converted instrument shares issued | 2,173,089 | |||||||||||||||||||||||||
| Cash payment | $ 184,864 | |||||||||||||||||||||||||
| Gains losses on extinguishment of debt | ||||||||||||||||||||||||||
| Warrants derivative | $ 1,278,786 | |||||||||||||||||||||||||
| Debt issuance costs | 207,361 | |||||||||||||||||||||||||
| Debt instrument derivative liabilities | 1,005,829 | |||||||||||||||||||||||||
| Debt Instrument, Increase, Accrued Interest | 237,230 | |||||||||||||||||||||||||
| Stock Issued During Period, Value, New Issues | 2,431,178 | |||||||||||||||||||||||||
| [custom:DerivativeLiability] | 509,303 | |||||||||||||||||||||||||
| [custom:GainLossRecognizedOfDebt] | $ 196,945 | |||||||||||||||||||||||||
| Series C Notes [Member] | Note Holders [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Exercise Price | $ 4.18 | |||||||||||||||||||||||||
| Series C Notes [Member] | Placement Agents Warrants [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Exercise Price | $ 2.09 | |||||||||||||||||||||||||
| Series C Notes [Member] | Placement Agent [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Placement agent fees description | The Company was obligated to pay the placement agent of the first series of Series C Notes a 10% cash fee for the face value of the notes. | |||||||||||||||||||||||||
| Series C Notes [Member] | Warrant [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Placement agent fees description | The Company was obligated to issue warrants that accompany the convertible notes and provide 100% warrant coverage. The warrants have a 4-year term from date of issuance and an exercise price that is 200% of the 5-day volume weighted average price of the Company’s common shares at the time of final closing. | |||||||||||||||||||||||||
| Series C Notes [Member] | Warrant [Member] | Placement Agent [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Placement agent fees description | The Company was also obligated to issue warrants to the placement agent that have a 10-year term and cover 8% of face value of the notes, with an exercise price that equals to the 5-day volume weighted average price of the Company’s common shares at the time final closing. | |||||||||||||||||||||||||
| Series C Convertible Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt converted amount | $ 1,487,700 | |||||||||||||||||||||||||
| Converted instrument shares issued | 2,173,089 | |||||||||||||||||||||||||
| Debt Instrument, Increase, Accrued Interest | $ 237,230 | |||||||||||||||||||||||||
| Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | 577,644 | |||||||||||||||||||||||||
| Stock Issued During Period, Value, New Issues | $ 2,431,178 | |||||||||||||||||||||||||
| [custom:SettlementOfDebt] | 2,234,232 | |||||||||||||||||||||||||
| [custom:DerivativeLiability] | 509,303 | |||||||||||||||||||||||||
| [custom:GainLossRecognizedOfDebt] | 196,945 | |||||||||||||||||||||||||
| Series C Note [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt Instrument, Increase, Accrued Interest | 34,864 | |||||||||||||||||||||||||
| Convertible Preferred Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Interest expense | 180,888 | 74,851 | ||||||||||||||||||||||||
| Short-term Bridge Loan Agreement [Member] | Collateralized Merchant Finance Company [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 24,000 | $ 9,999 | ||||||||||||||||||||||||
| Debt instrument carrying amount | 540,000 | 560,000 | ||||||||||||||||||||||||
| Adjustment for amortization | 6,142 | |||||||||||||||||||||||||
| Debt instrument periodic payment | 38,705 | 13,995 | 0 | |||||||||||||||||||||||
| Gross proceeds | $ 400,000 | $ 400,000 | ||||||||||||||||||||||||
| Debt instrument term | 98 days | 280 days | ||||||||||||||||||||||||
| Accretion expense | 66,213 | |||||||||||||||||||||||||
| Repayments of loan | ||||||||||||||||||||||||||
| Short-term Bridge Loan Agreement [Member] | Additional Collateralized Bridge Loan Agreement [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Gross proceeds | 700,000 | |||||||||||||||||||||||||
| Short-term Bridge Loan Agreement [Member] | Collateralized Merchant Finance Company One [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 35,000 | |||||||||||||||||||||||||
| Unamortized issuance cost discount | ||||||||||||||||||||||||||
| Debt instrument carrying amount | 1,008,000 | |||||||||||||||||||||||||
| Debt face amount | ||||||||||||||||||||||||||
| Adjustment for amortization | 26,879 | 8,121 | ||||||||||||||||||||||||
| Debt instrument periodic payment | 29,235 | |||||||||||||||||||||||||
| Gross proceeds | $ 700,000 | |||||||||||||||||||||||||
| Debt instrument term | 245 days | |||||||||||||||||||||||||
| Accretion expense | 193,015 | 114,985 | ||||||||||||||||||||||||
| Repayments of loan | 745,305 | |||||||||||||||||||||||||
| Short-term Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 32,000 | |||||||||||||||||||||||||
| Debt instrument carrying amount | 1,120,000 | |||||||||||||||||||||||||
| Adjustment for amortization | 20,800 | |||||||||||||||||||||||||
| Debt instrument periodic payment | 29,556 | |||||||||||||||||||||||||
| Gross proceeds | 800,000 | |||||||||||||||||||||||||
| Accretion expense | 148,027 | |||||||||||||||||||||||||
| Repayments of loan | ||||||||||||||||||||||||||
| Short-term Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | First Four Weeks [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument periodic payment | 13,999 | |||||||||||||||||||||||||
| Promissory Note Agreement [Member] | Individual Investor [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument carrying amount | $ 600,000 | 600,000 | 600,000 | |||||||||||||||||||||||
| Interest payable | 12,723 | 12,723 | ||||||||||||||||||||||||
| Debt instrument interest rate during period | 25.00% | |||||||||||||||||||||||||
| Interest expense | 150,000 | 150,411 | ||||||||||||||||||||||||
| Maturity date | Dec. 15, 2023 | |||||||||||||||||||||||||
| Early payment penalty provision percentage | 3.00% | |||||||||||||||||||||||||
| Promissory Note Agreement [Member] | Individual Investor One [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Interest payable | 86,455 | 7,101 | ||||||||||||||||||||||||
| Debt instrument interest rate during period | 12.00% | |||||||||||||||||||||||||
| Debt face amount | $ 660,504 | |||||||||||||||||||||||||
| Interest expense | 79,312 | 7,131 | ||||||||||||||||||||||||
| New Promissory Note [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Unamortized issuance cost discount | ||||||||||||||||||||||||||
| Debt instrument carrying amount | 270,000 | |||||||||||||||||||||||||
| Debt face amount | $ 270,000 | |||||||||||||||||||||||||
| Adjustment for amortization | 7,304 | |||||||||||||||||||||||||
| Maturity date | Dec. 31, 2023 | |||||||||||||||||||||||||
| Debt face amount | $ 248,479 | |||||||||||||||||||||||||
| Adjustment carrying value and principal amount | $ 21,521 | |||||||||||||||||||||||||
| Accrued interest | 50,000 | |||||||||||||||||||||||||
| Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 12,000 | |||||||||||||||||||||||||
| Debt instrument carrying amount | 420,000 | |||||||||||||||||||||||||
| Gross proceeds | 300,000 | |||||||||||||||||||||||||
| Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | First Four Weeks [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument periodic payment | 5,250 | |||||||||||||||||||||||||
| Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | Remaining Thirty Six Weeks [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt instrument periodic payment | $ 11,083 | |||||||||||||||||||||||||
| Additional Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Unamortized issuance cost discount | ||||||||||||||||||||||||||
| Debt instrument carrying amount | 980,000 | |||||||||||||||||||||||||
| Debt instrument periodic payment | 24,500 | |||||||||||||||||||||||||
| Adjustment for amortization | 2,800 | |||||||||||||||||||||||||
| Accretion expense | 4,152 | |||||||||||||||||||||||||
| Repayments of loan | 191,500 | |||||||||||||||||||||||||
| Loss on amendment of debt | $ 59,161 | |||||||||||||||||||||||||
| Two Short Term Promissory Notes [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Interest payable | 75,000 | |||||||||||||||||||||||||
| Debt face amount | $ 250,000 | 72,500 | ||||||||||||||||||||||||
| Administrative fees | 75,000 | |||||||||||||||||||||||||
| Two Short Term Promissory Notes [Member] | One Investor [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Gross proceeds | 500,000 | |||||||||||||||||||||||||
| Short Term Promissory Notes One [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt face amount | 250,000 | |||||||||||||||||||||||||
| Administrative fees | $ 25,000 | |||||||||||||||||||||||||
| Short Term Promissory Notes Two [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Debt face amount | 250,000 | |||||||||||||||||||||||||
| Administrative fees | 50,000 | |||||||||||||||||||||||||
| Short Term Bridge Loan Agreement One [Member] | Collateralized Merchant Finance Company [Member] | ||||||||||||||||||||||||||
| Short-Term Debt [Line Items] | ||||||||||||||||||||||||||
| Deferred finance costs | $ 15,750 | |||||||||||||||||||||||||
| Unamortized issuance cost discount | ||||||||||||||||||||||||||
| Debt instrument carrying amount | 844,200 | |||||||||||||||||||||||||
| Debt face amount | ||||||||||||||||||||||||||
| Adjustment for amortization | 10,023 | 5,727 | ||||||||||||||||||||||||
| Debt instrument periodic payment | 19,195 | |||||||||||||||||||||||||
| Gross proceeds | $ 630,000 | |||||||||||||||||||||||||
| Debt instrument term | 308 days | |||||||||||||||||||||||||
| Accretion expense | 93,895 | $ 120,305 | ||||||||||||||||||||||||
| Repayments of loan | $ 570,425 | |||||||||||||||||||||||||